Jil Sander for men and women
This article was originally published in The Rose Sheet
Executive Summary
New Jil Sander Scent 79 Woman and Jil Sander Scent 79 Man represent at once sophistication and purity - "a paradox held dear to Jil Sander," according to recent release. Jil Sander Scent 79 Woman, "crafted like haute couture clothing" by Symrise's Evelyne Boulanger, contains aldehyde accord, "sparkling" cranberries, white leathers and caramelized wood, "united by the fullness of vetiver," while packaging, designed by Peter Schmidt, is "emblematic of the Jil Sander style" with avant-garde vertical shape that stacks two symmetrical cubes together. Jil Sander Scent 79 Man, the creation of Symrise's Marc Buxton, has a "bold, contrasting personality"; notes include angelica root, clary sage, frankincense, as well as floral notes of jasmine, violet wood and orris concrete "atypical in the men's perfume world." Packaging consists of cube-over-cube structure slipped into black lacquered case with a white logo. Jil Sander Scent 79 Woman is priced at $110 for 4.2-oz. bottle, and Jil Sander Scent 79 Men at $90 for 4.2-oz. bottle. Both fragrances will be available in November exclusively at Neiman Marcus
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.